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Abstract
The authors discuss the challenging aspects of the diagnosis of tuberculosis in children 
and adolescents, since there is no gold standard for its diagnosis. The different clinical 
and radiological presentations and the low bacteriological positivity of tuberculosis in 
childhood are grounds for confrontation to the present. Immunological tests called inter‐
feron gamma release assays (IGRAs) failed to overcome the tuberculin skin test in prac‐
tice. Advances with nucleic acid amplification tests, on the other hand, have contributed 
to the diagnosis of tuberculosis among adolescents. Standardized systems for diagnosis 
can be useful as tools for screening or for decision‐making in childhood tuberculosis.
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1. Introduction
It is estimated that one‐third of the world population is infected by Mycobacterium tuberculosis 
and that each year about nine million people develop the disease, out of which 11% are chil‐
dren. This percentage can be higher in countries with high burden of tuberculosis (TB). At least 
one million children are sick with TB every year. In 2015, as many as 210,000 children died 
from TB, out of which 40,000 were patients coinfected with HIV [1, 2].
It is believed that genetic predisposition influences the resistance of certain individuals who, 
even in contact with patients with baciliferous TB, are not infected with M. tuberculosis [3].
In childhood, the distinction between infection and disease is often difficult. Some authors 
avoid the term latent TB (or latent TB infection) in children, preferring to use the term TB 
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infection. The progression of infection to disease can be subtle and go unnoticed. This dif‐
ficulty becomes more remarkable, often in extrapulmonary TB [2, 3].
From a practical point of view, the diagnosis of TB infection occurs when the child is asymp‐
tomatic with normal chest radiography and a reactive TB skin test (TST) or interferon gamma 
release assays (IGRA). On the other hand, the diagnosis of TB disease or active TB is a chal‐
lenge. It occurs when the child is symptomatic (with symptoms consistent with TB) and chest 
or other X‐ray is abnormal, compatible with TB. TST or IGRA can be reactive or not.
2. Differences between pulmonary tuberculosis in children and 
adolescents
The WHO has adopted standards for TB management in childhood that emphasize the impor‐
tance of clinical, radiological, and epidemiological data consistent with TB and bacteriologi‐
cal confirmation, where possible, to diagnose the disease. Anti‐HIV serology is also useful, 
especially in endemic areas of both diseases [4]. Even today these elements are essential for 
the diagnosis, since bacteriological confirmation is difficult in general, in children. Children 
mostly develop primary TB and are non‐bacilliferous or paucibacillary (in 80% of cases the 
diagnosis is made without bacteriological confirmation). Up to 7 or 8 years of age, children 
do not know how to expectorate properly to take samples for examination and, in addition, 
TB in this age group is usually paucibacillary, that is, with sputum smear negative. Recently, 
the incorporation of molecular diagnosis of TB allowed positive results in a higher percentage 
than those observed with the smear. Yet TB in children differs fundamentally from the disease 
in adults, as in childhood forms of negative TB prevail [4].
It is important to divide TB in childhood into two aspects. TB in children up to 10 years of age (TB 
in children) and from 10 years of age (TB in adolescents). In the first case, most of the forms are 
primary TB. In adolescents, most are adult‐type TB. That is, it is similar in clinical and radiological 
presentation to the pattern seen in adults. Adolescents are often bacilliferous and may transmit 
TB, develop excavated pulmonary forms, and, moreover, are able to cough and eliminate bacilli, 
similar to what occurs in adults [5, 6]. To collect specimens for bacteriological examination of 
children is only possible, most of the times, with the use of gastric lavage and induced sputum, 
since children under 5 or 6 years of age are almost unable to expectorate. The sputum smear or 
other specimen is processed by the traditional Ziehl‐Neelsen method. The culture can be per‐
formed by Loewstein‐Jensen method or liquid media—Ogawa or Middlebrook. More recently, 
molecular methods of nucleic acid amplification (NAATs) have been advocated. Among these 
methods, the Gene‐Xpert MTB/RIF method (Cepheid, California) was recommended by the 
WHO in 2013 to diagnose TB in childhood [5, 7, 8].
Note that in childhood, compared to a case with high clinical suspicion, although the bacterio‐
logical and molecular tests are negative, the diagnosis of TB can and should be done.
Serological diagnosis of childhood TB was insistently sought, as it does not depend on the 
bacterial burden in the lesions. This is an advantage in patients whose disease progresses with 
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small number of bacilli. However, a study with commercially available serum tests in 2011 
supported the WHO position of not recommending them for routine use. Thus, serological 
methods are no longer used as a diagnostic tool in children [3].
In adolescents, the diagnosis of TB may be bacteriologically proven in most cases. Patients 
from this age group with suspected TB are, most of the times, able to expectorate and are 
bacilliferous [5, 6, 9]. Soon, sputum smear microscopy can be a useful method, associated with 
clinical and radiological findings.
Table 1 shows differences in pulmonary TB in children and adolescents.
3. Basis for the clinico‐radiological diagnosis
Some risk factors for active TB in childhood continue to be valued for the diagnosis of active 
TB [4]:
• Intradomiciliary contact with a bacilliferous case recently diagnosed
• Under 3 years of age
• HIV infection
• Severe malnutrition
The clinical manifestations of TB, especially in young children, are subtle and may go unno‐
ticed. Discrete changes such as weight loss or lack of weight gain, fatigue, and decreased 
interest in playing and decreased physical activity can be frequent and sometimes are not 
noticed by the family. Unexplained fever, irritability, or nystagmus can be subtle findings in 
the early forms of meningoencephalitis caused by TB, for example. TB meningitis is a case of 
Children (primary TB) Adolescents (≥10 years old) (adult‐type TB)
Signs and symptoms: persistent fever, weight loss, 
interruption or loss in height and weight percentile, 
cough> 2 weeks, fatigue, night sweats
Signs and symptoms: persistent fever, cough >2 weeks, 
night sweats, weight loss, blood spitting
Contact with adult with TB There may be no history of contact with people with TB
Radiography: enlarged mediastinal lymph nodes, miliary 
pattern, pneumonia with no response to antibiotics
Radiography: infiltration in the upper third, excavations, 
pneumonia
Slow evolution pneumonia Slow evolution pneumonia
Reactive tuberculin skin test Reactive tuberculin skin test
Negative bacteriological tests Positive bacteriological tests (AFB and culture)
Positive Xpert * in a few cases (∼10%) Positive Xpert in most cases
*Gene‐Xpert MTB/RIF.
Table 1. Differences in pulmonary tuberculosis in children and adolescents.
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clear cerebrospinal fluid (CSF), the laboratory test of which shows a predominance of mono‐
cytes in the early stages and lymphocyte stage, in evolution, lower glucose blood sugar, and 
high levels of protein [4].
Pulmonary TB is taken into account in some situations, such as slow evolution pneumonia. 
Cases where the child is being treated with antibiotics for acute pneumonia and shows no good 
performance should be valued as suggestive of TB. Most relevant clinical data such as evening 
fever, weight loss, profuse night sweats, and coughing or combinations of these signs and symp‐
toms may facilitate suspected diagnoses of TB, especially if it has remained for over two weeks.
Some aspects remain as challenges for the diagnosis of TB in children. Young infants may 
present a subtle case of TB, with signs and symptoms that are confused with other infectious 
and noninfectious diseases. In such cases the diagnosis may be delayed by a longer or shorter 
time, depending on the diagnostic suspicion capacity of the health team, and its consequences 
can be disastrous. TB externalized as severe and acute pneumonia (patients admitted to ICU 
on ventilatory failure) is rare and difficult to diagnose. The suspected clinical appearance of 
TB in HIV‐infected patients or with severe malnutrition or the discovery of HIV in patients 
with TB almost always confuses doctors who are attending such patients. An extensive differ‐
ential diagnosis of diseases related to HIV immunosuppression, which are confused with TB 
is necessary. It is no less difficult to diagnose multidrug‐resistant TB (MDR‐TB) in children. 
In general, contact with adults with MDR‐TB is the key to establish such a diagnostic suspi‐
cion [2, 10]. The performance of susceptibility testing of patient specimens with suspected 
MDR‐TB is of limited use in childhood, because most cases are negative (no bacillus). When 
bacteriological examinations of the child cannot be done, but information is available on the 
sensitivity to adult drugs with which the child comes into contact, it can be assumed that 
his/her treatment is done with the same regimen of adult MDR‐TB. When the child’s clinical 
specimen is available and it is possible to perform Xpert, rifampicin resistance may be a proxy 
resistance to isoniazid. That is, there is high probability of being a case of MDR‐TB. More 
recently, Line‐probe assays have become available, which can simultaneously detect resistance 
to rifampicin and isoniazid. Another promising method is MTBDR‐sl, which detects resis‐
tance to fluoroquinolones, aminoglycosides, and ethambutol simultaneously. These latest 
tests are rarely used in childhood (Heemskerk, Guidance).
Although there is more radiological and clinical data suggestive of TB than others, the epide‐
miological context and the clinical picture have to be taken into account to achieve the diagno‐
sis of TB. Since there is no gold standard for the diagnosis of TB in childhood, it is necessary 
to consider the epidemiological reality of the region where the work is being done. Is it an 
endemic area for TB? Is the patient followed up in a basic health unit? Or in a reference center? 
Has the child with suspected TB had contact with an adult with TB or suspected TB? Was this 
a sporadic or lasting contact? Has the child suspected of intrathoracic TB been treated with 
antibiotics for common germs recently, with no successful result? All these questions may 
help contextualize the highest probability or not of diagnosing the disease in the child.
The possible contact of the child with an adult (especially if bacilliferous) is of great interest 
especially in young children. Infants and preschool children tend to have closer contact with 
adults than children of school age and adolescents. Thus, the history of contact with a per‐
son with TB can be epidemiologically valuable data on suspected TB diagnosis in childhood. 
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Household contact is more important than an external or sporadic one. However, in certain 
locations, the difference between household and external contact is subtle. In poor communi‐
ties, it is common for people to live together in neighboring houses; children are cared for by 
people in these communities and sleep in their relatives’ houses. So it is worth asking if the 
child has contact with other people supposedly with TB (cough> 3 weeks) in or out of his/her 
home. In nurseries or schools of endemic regions of TB, cases are sometimes discovered where 
employees or teachers with TB who were diagnosed late and may have infected children who 
interacted with them. A situation of extreme gravity is the occurrence of TB cases in pediatric 
intensive care units (PICU) or nurseries. Newborns in condition of extreme vulnerability can be 
infected by M. tuberculosis and can develop the disease, the diagnosis of which is often difficult.
It is known that the period of greatest risk of developing TB is the first 2 years following the 
primary infection by M. tuberculosis. This interval of 2 years is the most appropriate time to 
initiate preventive measures such as treatment of latent TB infection (isoniazid preventive 
therapy, IPT) [10].
4. Radiological diagnosis
The most common radiological patterns of pulmonary TB in children are hilar lymphadenop‐
athy identified on front X‐ray and more visible in profile incidence (Figure 1a and 1b); miliary 
Figure 1. (a and b) Enlarged hilar lymph glands: front and profile incidences (Primary TB).
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aspect—diffuse micronodular pattern in both hemithoraces, corresponding to hematogenous 
spread of TB (Figure 2) and appearance of alveolar pneumonia, that is, pattern of bacterial 
pneumonia caused by common germs, like pneumococcus, which may only be a case of TB 
when it becomes a case of slow evolution, not responsive to antibiotics (Figure 3) [4, 10]. It is 
often emphasized that many times we observe clinical and radiological dissociation in TB in 
children. The clinical evaluation of the child is disproportionately favorable in relation to the 
extent of radiation injury. That is, the radiological image suggests a serious pneumonia but 
the patient does not show signs of severity that would be expected in a pneumonia caused by 
common germs.
Figure 2. Micronodules in both lungs; miliary TB.
Figure 3. Slow evolution pneumonia; radiological aspect of a Pneumococcus pneumonia. Infiltrate on the left lung.
Mycobacterium - Research and Development104
Some of these radiological findings in suspected cases of TB in children always require some 
differential diagnoses. Thus, the miliary pattern may appear on acute histoplasmosis or lung 
metastases of neoplasm (Figure 4); the unilateral or bilateral adenomegalies may arise in the 
course of Hodgkin’s disease or sarcoidosis, and slow progression of pneumonia may also occur 
in atypical pneumonia (for Mycoplasma, for example), pneumonia caused by common germs, 
actinomycosis, nocardiosis, and other noninfectious agents in immunocompromised patients.
In adolescents, radiological aspects are identical to the pattern seen in adults: adult‐type TB 
(Figure 5).
Figure 4. Micronodules in both lungs. Aspect of miliary TB. In fact, it was a thyroid carcinoma with metastases.
Figure 5. Pulmonary infiltrate in upper zone of the right lung. Aspect of TB adult type.




The main methods of immunological diagnosis of TB are the tuberculin skin test (TST) and 
interferon gamma release assay or IGRA.
The TST with PPD, conducted by the Mantoux technique, introduced in 1907, is the intrader‐
mal injection of 5 tuberculin units (TU) of purified protein derivative PPD‐S (PPD) or 2 TU 
PPD RT23 (are equivalent). In the event of cellular immunity to such tuberculin antigens, a 
delayed hypersensitivity reaction will occur within 48–72 h [11].
The reaction will cause skin induration at the injection site, and its transverse diameter must 
be measured (induration mm) by a trained individual and interpreted using stratified cutoffs: 
0–4 mm = no reaction; 5 mm or more = reaction.
Immunity measured by TST may also reflect exposure to other environmental mycobacteria, 
vaccination by BCG (Bacillus Calmette–Guérin‐Mycobacterium bovis), or a previous TB infec‐
tion. This type of reactivity can lead to false‐positive results. On the other hand, false negative 
results may occur especially in immunosuppressed people, for example, with advanced HIV 
infection or using immunosuppressive medication [3].
The IGRA is an in vitro test which detects the production of IFN‐γ in peripheral blood by 
T cells of the host infected by M. tuberculosis. The identification of immunogenic proteins 
of the mycobacteria, antigens ESAT‐6, CFP‐10, and TB 7, which are specifically expressed 
by pathogenic strains of M. tuberculosis complex, allowed the development of IGRA. These 
antigens are encoded in the region of difference 1 (RD1) of the genome of M. tuberculosis. 
RD1 contains genes encoding the secretive system of the bacillus, known as ESX‐1. Such 
antigens are very specific of M. tuberculosis although there is some evidence of cross‐reactiv‐
ity with Mycobacterium leprae, not yet proven; positive results in individuals infected with 
Mycobacterium marinum and Mycobacterium kansasii have also been evidenced [3, 11].
There are two types of IGRA. The test conducted by QuantiFERON TB Gold methodology 
allows the measurement of in vitro level of IFN‐γ produced by T cells that have been stimulated 
by the said antigens. The result is reported as number of IFN‐γ in international units (IU) per 
milliliter. An individual is considered positive if the amount of IFN‐γ is above the cutoff point 
of the test (considering the negative control). Another method may be used: T‐SPOT.TB. It is an 
immunosorbent assay (ELISPOT) performed in separate and counted mononuclear cells from 
peripheral blood which are incubated with ESAT‐6 and CFP‐10 antigens. The result is reported 
as the number of T‐cells producing IFN‐γ (spot‐forming cells). An individual is considered pos‐
itive if the points count in the antigens exceeds the negative control points. Indeterminate IGRA 
results may occur due to a low IFN‐γ response of the positive control (mitogen) or a high IFN‐γ 
response of the negative control. Further studies are needed on this test in children [7, 11].
6. IGRA and TST in tuberculosis diagnosis in children
The purpose of carrying out the TST or IGRA in children is to determine whether there is 
or not M. tuberculosis infection while other factors such as contact history and clinical and 
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radiological picture will allow diagnosis. Thus, the negative result of these tests does not 
exclude TB disease, nor does its positive result confirm it. Both tests have limitations inher‐
ent in specific methodologies and rationales. In addition, IGRAs are still poorly studied in 
children living in regions with high TB prevalence or HIV‐infected children [7]. Some studies 
suggest that in children above 5 years of age vaccinated with BCG, IGRAs may be preferred to 
the TST, whereas in children who have not been vaccinated with BCG, the IGRAs and TST are 
equally indicated. In Brazil, to consider a child to be infected with TB, the cutoff point of the 
TST ≥ 5mm was adopted in children vaccinated more than 2 years or in immunosuppressed 
children; in children vaccinated with BCG less than 2 years, the cutoff point is ≥ 10 mm. These 
cutoff points were decided as above, since during the 2 years after the application of BCG vac‐
cine, the TST reaction will gradually decline [6].
IGRAs and TST alone do not allow the diagnosis of TB disease; its role is to indicate TB infec‐
tion. Both tests have a similar sensitivity for detecting infection by M. tuberculosis. More stud‐
ies are needed in children, because IGRAs still yield indeterminate results, which are justified 
by the low capacity of producing immunoglobulins in children in early childhood. In patients 
infected with HIV, the sensitivity of IGRAs is low, similar to what occurs with the TST [11].
The cost of IGRAs is much higher and is also technically more complex than the TST. 
Furthermore, it involves collecting blood, which is a limitation in the case of children. On the 
other hand, the TST requires two visits to the clinic in order to get the result within 48–72 h. 
The trend of international standards is to keep the TST as a standard for identifying cases of 
TB infection, at the expense of IGRAs, due to the advantages of the TST in terms of cost, more 
reliable results in small children, and lack of need for laboratory resources [4].
Table 2 lists the main differences between IGRAs and TST.
Characteristic TST IGRA
Antigens used Many, PPD 3 (QFT) or 2 (T‐SPOT)
Sample Intradermal injection Blood draw
Patient visits required 2 1
Distinguish between Latent TB and 
TB disease
No No
Cross‐reactivity with BCG Yes No
Cross‐reactivity with non‐TB 
mycobacteria
Yes Only rare species *
Differing positive values by risk Yes (5‐10‐15) No
Causes boosting Yes No
Subject to boosting by previous TST Yes Possible
Durability over time (stays positive 
with or without treatment)
Yes Unknown
Difficulties with test reproducibility Yes Yes
Relative cost Lower Higher
Location of need for trained staff “Bedside” Laboratory




The Xpert MTB‐Rif system (Xpert) is a test based on nucleic acid amplification used to detect 
M. tuberculosis and for the screening of drug‐resistant strains. It uses real‐time polymerase chain 
reaction (PCR) technique, on the Gene Xpert platform, which allows to integrate three processes: 
purification, concentration, and amplification of nucleic acids by polymerase chain reaction 
(PCR) and detection of nucleic acid sequences in the genome of M. tuberculosis, specifically in 
rpoβ gene. This technique does not require mycobacterial DNA manipulation after amplification 
and thus reduces the complexity and risk of cross reactivity by DNA product amplification [12].
Not only does it allow, in a period of 2 h in the laboratory, to identify M. tuberculosis but also 
to detect bacterial resistance to rifampicin (RIF) by amplification, using PCR, of five overlap‐
ping probes which are supplemental to the region determining RIF resistance, consisting of 
81 base pairs of rpoβ gene in M. tuberculosis. Then, this region is examined in order to identify 
mutations associated with resistance [3].
It is a quick, highly automated test and does not depend upon the machine operator. The only 
manual step involves adding the correct dose of the reagent into the specimen under analysis, 
and it is subsequently homogenized for 15 min and transferred to the Xpert cartridge.
The system consists of a Gene Xpert instrument, a computer, a barcode reader, and a prein‐
stalled software to perform tests on samples taken and to view the results generated on the 
screen and to report as negative or positive M. tuberculosis, as well as to report whether sen‐
sitive or not to RIF. However, a positive result does not necessarily indicate the presence of 
viable bacilli, since the method can identify the DNA of live or dead microorganisms [7, 12].
Various specimens (organic liquids, aspirated peripheral ganglia) can be processed, but its 
main application is in sputum samples, and its wider applicability is in adults with suspected 
pulmonary tuberculosis [7]. Its use in extrapulmonary samples still has a variation between 
different studies, in terms of sensitivity and specificity according to the analyzed material, as 
well as considerations related to cost‐effectiveness in these samples [13].
Characteristic TST IGRA
Estimated specificity in BCG‐
unvaccinated children
95–100% 90–95%
Estimated specificity in BCG‐
vaccinated children
49–65% 89–100%
Estimated sensitivity (confirmed TB 
disease)
75–85% 80–85%
Estimated sensitivity (clinical TB 
disease)
50–70% 60–80%
*M. marinum, M. kansasii, Mycobacterium szugai, Mycobacterium flavescens.
Source: Ref. [11].
Table 2. Comparison of the TST and IGRA.
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The following samples should not be processed: those composed exclusively of saliva; con‐
taining food particles; consisting solely of pus (no mucus and greenish); consisting exclu‐
sively of blood; with quantity less than 1 ml in the case of pulmonary and extrapulmonary 
samples, except cerebrospinal fluid (CSF); CSF samples amounting to less than 0.1 ml.
The sensitivity and specificity values for a single Xpert in adult sputum approach 88% (95% 
CI: 83–92) and 98% (95% CI: 97–99), respectively. Among those with positive sputum smear, 
the sensitivity is around 98% (95% CI: 97–99) and among those with negative sputum smears, 
it is around 68% (95% CI: 59–75) [14].
Xpert has still limited use in childhood, since its excellent performance is seen in bacteriologi‐
cally confirmed TB, which is the minority of cases in children [7]. It has been shown that, by 
using culture as the gold standard, the sensitivity of Xpert on a single test in children under 
15 years of age is from 42.9 to 90%, both in sputum and in induced sputum [13, 15, 16]. For the 
gastric lavage samples, sensitivity is 68.8% [15] and for nasopharyngeal aspirate it is 48% [17]. 
Specificity is similar to the adult (over 98%). A second test in children with negative sputum 
smears may increase the sensitivity of Xpert in 27.8% [13].
The prospect of broadening the diagnosis of TB in children with the use of Xpert was the subject 
of some studies carried out in South Africa and other African countries. There was higher posi‐
tivity of Xpert in cases of PT in relation to culture for M. tuberculosis on specimens, such as gastric 
lavage, nasopharyngeal aspirate, and sputum induction. It became clear that Xpert contributes 
to increased diagnostic capacity of pulmonary TB in microbiologically confirmed TB [12, 17].
In Detjen and colleagues meta‐analysis with studies using Xpert for the diagnosis of pulmo‐
nary TB in children and adolescents, the pooled sensitivities and specificities of Xpert for 
TB detection, when compared to culture: 62% (IC 95%: 51–73) and 98% (IC954%: 97–99) in 
sputum and induced sputum, respectively, and for samples from gastric lavage: 62% (95% 
CI: 51–73) and 98% (95% CI: 96–99), respectively. When compared with microscopy, the Xpert 
sensitivity was better [18].
In New Delhi, India, in a study investigating suspected cases of pediatric TB in public ser‐
vices, it was observed that Xpert was able to detect twice as many cases of pulmonary TB 
compared to smear and to increase the capacity to detect resistance to RIF, which is a quick 
and promising test for pediatric patients [19].
8. The role of clinical examination
The clinical examination does not always contribute significantly to the diagnosis of TB in 
children. It is recommended to evaluate the child’s weight and development and to identify 
possible growth retardation attributable to the chronic nature of TB. In adolescents the clini‐
cal examination can be more informative: weight loss, poor general condition and presence 
of cough, and sometimes, blood spitting, call the doctor’s attention to the possibility of the 
disease. Physical examination changes in the respiratory tract, such as bronchial or cavernous 
breath, have been reported for decades in patients with excavation (caverns) in the lungs, but 
they are currently little researched or recognized. Occasionally, wheezing in the chest can be 
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located by auscultation, due to extrinsic compression of the bronchi by mediastinal lymph‐
adenopathy [10].
Extrapulmonary manifestations of TB may be evident on clinical examination, such as periph‐
eral lymphadenopathy. Peripheral lymph node TB can present with cervical lymphade‐
nopathy with progressive worsening, sometimes fistulated (scrofuloderma). Osteoarticular 
tuberculosis affecting the column (Pott disease) can present, insidiously, with back pain and 
night crying, deformity in the column, and difficulty in walking. Meningoencephalitis in the 
early stages evolves with discrete findings such as conjugate deviation of the eyes, irritability, 
vomiting, and behavioral changes, reaching to severe cases of neck stiffness. Pleural TB, most 
common in children and adolescents, may manifest as a pleural syndrome without apparent 
cause, with afebrile patient, or low fever and with no difficulty breathing even in cases of 
large spills. Cutaneous TB in general is difficult to diagnose by multiple lesions that it can 
determine. An experienced dermatologist in general needs to be contacted.
The manifestation of skin that most commonly can relate to TB is erythema nodosum. 
This transient injury, usually in the anterior tibial crest, may arise in TB primary infection. 
However, causes such as streptococcal infections, drug reactions, and leprosy, among others, 
should always be considered in these cases [4, 8].
Remember that extrapulmonary manifestations associated with pulmonary TB can be seen 
with some frequency. Thus, when one is investigating a suspected case of extrapulmonary 
TB, such as meningoencephalitis, bone, or other location, chest X‐ray is recommended concur‐
rently. Although the patient is asymptomatic for lung, pulmonary radiological damage may 
occur silently, which will ultimately assist in the diagnosis of TB.
Cases of pulmonary TB with severe course, resulting in ventilatory insufficiency, are uncom‐
mon but require the experience of an intensive care team to reach the diagnosis. Severe acute 
pneumonia of rapid course, similar to those caused by common germs, was described in 
infants and children with HIV. Clinical findings such as oral candidiasis, parotid hypertro‐
phy, and digital clubbing can be seen in HIV‐infected patients, in which TB‐HIV coinfection 
can be considered. Lymphocytic interstitial pneumonia, currently uncommon, is a chronic 
process associated with the HIV virus that mimics the miliary TB. It is pneumonia with diffuse 
micronodular interstitial pattern, similar to Pneumocystis jirovecci, which can affect patients 
with HIV/AIDS and whose differential diagnosis of TB is a challenge [10].
The diagnosis of TB should also be sought in child living with an adult with TB, even if it is 
asymptomatic. This is the case of asymptomatic contacts. The contact control is one of the 
most valued preventive measures of TB in childhood, because it allows diagnosing TB cases 
at an early stage and taking preventive measures, such as the IPT, provided that the existence 
of active TB can be ruled out. Asymptomatic contact should preferably be submitted to chest 
radiography and TST or IGRA. If the X‐ray is abnormal, compatible with TB, regardless of the 
result of the TST/IGRA, the child must be considered as a case of TB and justifies starting treat‐
ment of the disease. If the X‐ray is normal and the TST/IGRA is reactive, IPT is indicated [4, 10].
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9. Clinical classification of intrathoracic tuberculosis in children
The international consensus proposed in 2015 aimed at clinical standardization of intratho‐
racic TB cases in childhood called for, among others, the following clinical findings suggestive 
of TB: persistent cough for ≥ 2 weeks, growth arrest in the last 3 months (documented), and 
fatigue [20].
Standardizing sought to establish parameters for research in TB area, so that the terms used 
are easy to understand and even among researchers. It also facilitates the clinical approach 
and can be used in routine care.
Based on the clinical, radiological, and epidemiological findings, in immunological confir‐
mation of M. tuberculosis infection and bacteriological confirmation, the following rating for 
intrathoracic TB in childhood was proposed [20]:
1. TB confirmed—Finding of M. tuberculosis (Culture or Xpert MTB/RIF) in at least one res‐
piratory specimen.
2. TB not confirmed—No bacteriological confirmation and at least 2 of the following 
findings: signs and symptoms suggestive of TB; chest radiograph compatible with TB; 
close contact or evidence of immune infection by M. tuberculosis; Positive response to 
treatment.
Infected by M. tuberculosis—immunological evidence of infection by M. tuberculosis (positive 
TST or IGRA).
Not infected by M. tuberculosis—with no immunological evidence of infection.
3. TB unlikely—No bacteriological confirmation of TB; no criteria of unconfirmed TB, and 
no evidence of infection by M. tuberculosis.
10. Algorithms and scoring systems for diagnosis
For more than four decades, algorithms and scoring system have been published for diagno‐
sis of TB in childhood. Some were validated and others were not. In Brazil, a scoring system is 
used for the diagnosis of pulmonary TB (intrathoracic) since 2002, which has been validated 
in HIV‐infected and HIV‐uninfected children [9, 21] and already tested in other countries [22, 
23]. In HIV‐infected patients, the system scored better sensitivity than specificity, becoming 
therefore more suitable as a screening test [24].
In HIV‐uninfected children, the system provided sensitivity and specificity values greater than 
86%. One of the advantages of this system is that it requires no bacteriological confirmation, 
which is admittedly useful in small children unable to expectorate (Table 3).




The diagnosis of TB in children is based on clinical and radiological features adding other 
data as epidemiological and immunological (TST or IGRAs) information. In children (<10 
years old) the bacteriological confirmation is difficult because in these individuals the TB is 
negative. There are few cases in which we can establish the disease confirmation due to the 
etiopathogenesis of primary TB. Primary TB means a disease of a small quantity of bacillus 
(M. tuberculosis). However, in adolescents (>10 years old) the TB assumes other characteristics: 
it is an adult type TB. In this form of TB the majority of the patients are bacilliferous (positive), 
so the bacteriological confirmation is possible. So, the molecular diagnosis using Gene‐Xpert 
MTB/RIF test is adopted in several endemic countries with good results.
Characteristic Points
Clinical manifestations
Fever or cough, lost energy, sputum, weight loss, or night 
sweats for >2 weeks
+15
No symptoms or symptoms for <2 weeks +0
Respiratory infection improving with or without antibiotic 
treatment for common bacteria
−10
Thoracic X‐ray
Hilar adenomegaly or miliary pattern +15
Exudate or patch shadow (with or without cavitation) 
unaltered/worsening after > 2 weeks with antibiotic 
treatment for common bacteria
+15






None or occasional contact 0
BCG vaccination and TST
BCG ≥2 years ago or no BCG, TST >5 mm +15
BCG <2 years ago, TST >10 mm +15
TST ≤5 mm, regardless of BCG 0
Nutritional status
Severe malnutrition (grade III) +5
Eutrophic or non‐severe malnutrition 0
Table 3. Guide for Brazilian ministry of health diagnostic system.
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12. Projections and applications
As the diagnosis of pediatric TB is a challenge, we consider that the professional capacitating 
is necessary for enhancing the despistage of cases in childhood. Till today, the only diagnostic 
tool for childhood TB is the Gene Xpert TB test. However, this test is almost only useful in ado‐
lescents who have a bacteriological disease. The majority of cases in children depend on the 
health professional capacity of interpreting clinico‐radiological and epidemiological aspects 
aiming to establish the correct diagnosis of TB.
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